Take a look at some of the biggest movers in the premarket:
Virgin Galactic (SPCE) – Virgin Galactic shares rose 28.2% in the premarket after it was announced that founder Richard Branson plans to be on board a scheduled space flight on July 11th. The flight would take 9 days before a scheduled Blue Origin flight would take its founder, Amazon's Jeff Bezos, into space.
Didi (DIDI) – The shares of the China-based ride-hailing company gave up a pre-trading profit after it was announced that the Chinese Cyberspace Administration will conduct a cybersecurity investigation into Didi's activities. It also asked Didi to stop registering new users during the investigation. The Didi share collapsed after this news in the premarket by 5.5%.
Krispy Kreme (DNUT) – Donut chain stocks fell 5% in pre-trading hours, returning a portion of the 23.5% gain recorded on Thursday's first day of trading. Krispy Kreme returned to the public markets yesterday, five years after being privatized.
Apollo Global (APO) – The private equity firm announced it will acquire a stake of up to 24.9% in financial technology investor Motive Partners. The Wall Street Journal reported that Motives for the transaction is valued at approximately $ 1 billion. Apollo lost 2.4% in the premarket.
Johnson & Johnson (JNJ) – J&J said its Covid-19 vaccine shows promise against the Delta variant and other emerging strains of the virus. It also said that the immune response among vaccine recipients lasted at least eight months.
Raytheon Technologies (RTX) – The defense company won an Air Force contract worth $ 2 billion to manufacture a nuclear-armed cruise missile. The rocket is expected to be designed and manufactured by February 2027.
Verizon (VZ) – Verizon announced to regulators that it would continue to support low-cost cellular services if it were allowed to close its $ 6.9 billion deal to purchase prepaid cellular operator Tracfone.
Tesla (TSLA) – A Pennsylvania driver's attorney told Reuters that a Tesla Model S plaid model went up in flames while the owner was driving, just three days after it was delivered. Tesla did not have an immediate opinion.
GlaxoSmithKline (GSK) – The drug maker responded to a letter from activist investor Elliott Advisors, saying it welcomes all constructive contributions from shareholders who help create long-term value. Elliott announced a stake in Glaxo earlier this week and asked, among other things, to consider selling its consumer health care division.
PNC Financial (PNC) – Wolfe Research gave the banking company a double upgrade to “outperform” from “underperform”. Wolfe considers PNC's earnings outlook to be particularly optimistic due to the takeover of the US unit of Spanish bank BBVA.
CureVac (CVAC) – The German drugmaker's stock slumped 4.1% early on, adding to the 7.7% decline on Thursday. It was followed by news that his Covid-19 vaccine showed 48% effectiveness in updated study results, only marginally better than the initial results.